Clinical Trial

Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy

Study acronym: Replexa+
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This research project is designed to see if treatment with the Replexa+ shortwave diathermy device daily for 3 months will improve blood flow in the lower legs and feet of patients diagnosed with peripheral artery disease and peripheral neuropathy.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Not Yet Recruiting 2026-05-30
notable Primary completion pushed: 2026-12-31 -> 2027-12-31 2026-05-30
minor Completion pushed: 2026-12-31 -> 2027-12-31 2026-05-30
Trial Details
NCT Number NCT07336381
Lead Sponsor Indiana University
Collaborators: ProMedTek, Inc.
Conditions Peripheral Arterial Disease, Peripheral Neuropathy
Enrollment 10 participants
Start Date 2026-07-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-29